Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON39388
NL-OMON39388
Recruiting
Not Applicable

A pilot study on the efficacy and pharmacokinetics of a switch from nevirapine with emtricitabine, tenofovir or lamivudine, tenofovir or lamivudine, zidovudine to rilpivirine with emtricitabine, tenofovir in virologically suppressed HIV-1 infected patients. - rilpivirine switch study

Erasmus MC, Universitair Medisch Centrum Rotterdam0 sites50 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Enrollment
50
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Able to take medication with a 500 kcal meal
  • •Treated with NVP and FTC, TDF or 3TC, TDF or 3TC, ZDV for at least the last 9 months
  • •No history of HIV virologic failure
  • •The last 2 measured HIV\-RNA levels in plasma were \<50 copies/ml
  • •\>\=6 months between the first and last plasma with \<50 copies/ HIV RNA/ml

Exclusion Criteria

  • •Use of proton pump inhibitors.
  • •Use of H2\-antagonists
  • •Use of other contraindicated concurrent medication

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
A pilot evaluation of the pharmacokinetics, efficacy and safety of switching from efavirenz to maraviroc administered at 600mg then 300mg twice-daily in patients suppressed on an efavirenz-containing regimen as initial therapy - Pharmacokinetics of switching from efavirenz to maravirocHIV
EUCTR2009-014694-40-GB12
Completed
Phase 2
Siddha treatment for Joint pai
CTRI/2010/091/006125ational Institute of Siddha Chennai Tamil Nadu India40
Recruiting
Phase 2
A pilot study to evaluate the therapeutic efficacy of kurosani ommumsathu (internal) in the management ofthookaminmai (insomnia)Health Condition 1: null- THOOKAMINMAI(INSOMNIA)
CTRI/2014/04/004520ATIONAL INSTITUTE OF SIDDHA10
Not yet recruiting
Phase 2
A Study to find the Effectiveness of Siddha treatment for Vathakarsanam (Diabetic Peripheral Neuropathy)Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications
CTRI/2024/06/069492I
Not yet recruiting
Phase 2
Clinical Study to evaluate the effectiveness of Linga chendooram in the management of Uthiravatha suronitham (Rheumatoid arthritis)Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified
CTRI/2023/09/057492I